المؤلفون: Hanh Dufat, Sina Ros, Farid Boumediene, Noudy Sengxeu, Chanraksmey Aon, Jeremy Jost, Samleng Chan, Voa Ratsimbazafy, Pierre-Marie Preux

المساهمون: Grelier, Elisabeth, Neuroépidémiologie Tropicale (NET), CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), Cibles Thérapeutiques et conception de médicaments (CiTCoM - UMR 8038), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Service de l'Information Médicale et de l'Évaluation [CHU Limoges] (SIME), CHU Limoges, Laboratoire de Biostatistique et d'Informatique Médicale, Université de Limoges (UNILIM), Service de Pharmacie Centrale [CHU Limoges], Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)

المصدر: Epilepsia Open, Vol 6, Iss 3, Pp 548-558 (2021)
Epilepsia Open
Epilepsia Open, 2021, ⟨10.1002/epi4.12514⟩
Epilepsia Open, The International League Against Epilepsy 2021, ⟨10.1002/epi4.12514⟩

مصطلحات موضوعية: Asia, Seizure medication, media_common.quotation_subject, 030231 tropical medicine, Pharmacy, Poor quality, 03 medical and health sciences, Epilepsy, 0302 clinical medicine, Environmental health, medicine, Humans, Quality (business), RC346-429, media_common, anti‐seizure medication, treatment gap, Medical treatment, business.industry, anti-seizure medication, Carbamazepine, respiratory system, medicine.disease, musculoskeletal system, 3. Good health, respiratory tract diseases, accessibility, Cross-Sectional Studies, Neurology, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Costs and Cost Analysis, Full‐length Original Research, epilepsy, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Neurology (clinical), Neurology. Diseases of the nervous system, Rural area, Cambodia, Drugs, Essential, business, 030217 neurology & neurosurgery, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d779bf2cbe989d140f6e8102fb50fd
https://doaj.org/article/35e9a3f3add449368e55299f96c9d7ee

المؤلفون: Darshanand Maraj, Nav Persaud, Dalton R. Budhram, Ri Wang, Krish Bilimoria, Simran Benipal

المصدر: Canadian Journal of Diabetes. 46:S4

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Population health, 030204 cardiovascular system & hematology, Essential medicines, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Interquartile range, Diabetes mellitus, Environmental health, Outcome Assessment, Health Care, medicine, Per capita, Diabetes Mellitus, Internal Medicine, Humans, Developing Countries, Cause of death, business.industry, 1. No poverty, General Medicine, medicine.disease, Confidence interval, Health equity, 3. Good health, Cross-Sectional Studies, business, Drugs, Essential

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f20ecac0459b26967b3c5616820f9892
https://doi.org/10.1016/j.jcjd.2022.09.011

المؤلفون: Manuela De Allegri, Jean-Claude Taptué Fotso, Anne-Marie Turcotte-Tremblay, Habakkuk Azinyui Yumo, Isidore Sieleunou, Denise Magne Tamga, Valéry Ridde

المصدر: Health Policy and Planning

مصطلحات موضوعية: Drug Industry, Health Personnel, media_common.quotation_subject, 030231 tropical medicine, Psychological intervention, Supplement Articles, essential medicines, Essential medicines, Nonprobability sampling, 03 medical and health sciences, 0302 clinical medicine, Healthcare Financing, Humans, Cameroon, 030212 general & internal medicine, Marketing, Reimbursement, Incentive, Qualitative Research, media_common, Pharmacies, Health Policy, 1. No poverty, Performance-based financing, essential drugs, 3. Good health, Management system, Accountability, Business, Thematic analysis, Drugs, Essential, Autonomy, Qualitative research

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::540ec2f03d6ad49471675e510bc1f81a
https://doi.org/10.1093/heapol/czz084

المؤلفون: Nav Persaud, Jordan D Jarvis, Adrianna Murphy, Pablo Perel

المصدر: Canadian Medical Association Journal. 191:E1093-E1099

مصطلحات موضوعية: Canada, Prescription drug, Attitude of Health Personnel, Decision Making, Essential medicines, Interviews as Topic, 03 medical and health sciences, 0302 clinical medicine, Political science, Humans, 030212 general & internal medicine, Formulary, Qualitative Research, Health policy, Government, business.industry, Research, Health Policy, General Medicine, Public relations, Private sector, 3. Good health, 030220 oncology & carcinogenesis, Thematic analysis, Drugs, Essential, business, Qualitative research

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399be25583ef031cf264ea31dff35062
https://doi.org/10.1503/cmaj.190567

المؤلفون: Michael Sergio Taglione, Nav Persaud

المصدر: BMJ Open, Vol 11, Iss 8 (2021)
BMJ Open

مصطلحات موضوعية: medicine.medical_specialty, Cross-sectional study, 030204 cardiovascular system & hematology, World Health Organization, Essential medicines, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, 030212 general & internal medicine, Developing Countries, Health policy, Income.status, 2. Zero hunger, international health services, business.industry, Public health, Developed Countries, health policy, General Medicine, 3. Good health, Cross-Sectional Studies, Family medicine, Income, Medicine, Public Health, business, Drugs, Essential, High income countries

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4892ffb2f07744b6dd3b38dd1c7c2368
https://bmjopen.bmj.com/content/11/8/e045262.full

المؤلفون: Karine Reybier, Pierre Perio, Chinedu O. Egwu, Ioannis Tsamesidis, Jean-Michel Augereau, Françoise Benoit-Vical

المساهمون: Pharmacochimie et Biologie pour le Développement (PHARMA-DEV), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie de Toulouse (ICT-FR 2599), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Institut de Chimie du CNRS (INC)-Institut de Recherche pour le Développement (IRD), Alex Ekwueme Federal University Ndufu-Alike, Ikwo (AE-FUNAI), Laboratoire de chimie de coordination (LCC), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie de Toulouse (ICT-FR 2599), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, New Antimalarial Molecules and Pharmacological Approaches (ERL1289), Centre d'investigation clinique de Toulouse (CIC 1436), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Institut de Chimie de Toulouse (ICT), Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Université Toulouse III - Paul Sabatier (UT3), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), ANR-16-CE35-0003,INMAR,Réseau intégré des mécanismes de quiescence & clairance impliqués dans la résistance à l'artémisinine chez Plasmodium(2016)

المصدر: Free Radical Biology and Medicine
Free Radical Biology and Medicine, Elsevier, 2021, 167, pp.271-275. ⟨10.1016/j.freeradbiomed.2021.03.001⟩
Free Radical Biology and Medicine, 2021, 167, pp.271-275. ⟨10.1016/j.freeradbiomed.2021.03.001⟩

مصطلحات موضوعية: 0301 basic medicine, Artemisinins, medicine.medical_treatment, Plasmodium falciparum, Drug Resistance, Dihydroartemisinin, Pharmacology, Mechanism of action, Biochemistry, 03 medical and health sciences, chemistry.chemical_compound, Antimalarials, 0302 clinical medicine, Superoxides, Chloroquine, Physiology (medical), parasitic diseases, medicine, [CHIM.COOR]Chemical Sciences/Coordination chemistry, Artemisinin, biology, Superoxide radicals, Superoxide, biology.organism_classification, 3. Good health, LC-MS, 030104 developmental biology, chemistry, medicine.symptom, Drugs, Essential, 030217 neurology & neurosurgery, Atovaquone, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::562bc4b52214d70cd4dca5a5b5b70d8d
https://hal.archives-ouvertes.fr/hal-03203905

المؤلفون: Lilian Mbau, Kara Hanson, Adrianna Murphy, Martin McKee, Els Torreele

المصدر: BMJ Global Health
BMJ Global Health, Vol 6, Iss 2 (2021)

مصطلحات موضوعية: Economic growth, 2019-20 coronavirus outbreak, COVID-19 Vaccines, Phase iii trials, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), World Health Organization, Essential medicines, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, 0302 clinical medicine, cardiovascular disease, Pandemic, Humans, lcsh:RC109-216, 030212 general & internal medicine, China, Pandemics, Health policy, lcsh:R5-920, SARS-CoV-2, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, COVID-19, vaccines, 3. Good health, Commentary, Business, lcsh:Medicine (General), Drugs, Essential, 0305 other medical science, health systems

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f73700cc6ae2a8eeb9cd98e156f8d99
https://doi.org/10.1136/bmjgh-2021-005158

المؤلفون: Kim Ward, Bvudzai Priscilla Magadzire, David Sanders, H.M.J. Leng

المصدر: South African Medical Journal, Vol 107, Iss 7, Pp 581-584 (2017)
South African Medical Journal; Vol 107, No 7 (2017); 581-584
SAMJ: South African Medical Journal, Volume: 107, Issue: 7, Pages: 581-584, Published: JUL 2017

مصطلحات موضوعية: Procurement, Medication Therapy Management, lcsh:Medicine, Context (language use), Distribution, Health Services Accessibility, 03 medical and health sciences, South Africa, 0302 clinical medicine, Health facility, Medicine, Humans, Medicines supply, Stock-outs, 030212 general & internal medicine, Marketing, Qualitative Research, Call for bids, lcsh:R5-920, Public Sector, business.industry, 030503 health policy & services, Public sector, lcsh:R, General Medicine, 3. Good health, Needs assessment, Drug and Narcotic Control, 0305 other medical science, business, Drugs, Essential, lcsh:Medicine (General), Critical Incident Technique, Delivery of Health Care, Needs Assessment, Qualitative research

وصف الملف: application/pdf; text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80556125e7bc11d99bd9d42caadb0d96
http://www.samj.org.za/index.php/samj/article/view/11937/8102

المؤلفون: Aaron S. Kesselheim, Mehdi Najafzadeh, David G. Li, Arash Mostaghimi

المصدر: The BMJ

مصطلحات موضوعية: Medicare Part D, Beneficiary, 030204 cardiovascular system & hematology, Medicare, World Health Organization, World health, Essential medicines, Drug Costs, 03 medical and health sciences, 0302 clinical medicine, Health care, Outcome Assessment, Health Care, Medicine, Drugs, Generic, Humans, 030212 general & internal medicine, Medical prescription, Unit cost, Retrospective Studies, business.industry, Research, Retrospective cohort study, General Medicine, United States, 3. Good health, Health Expenditures, business, Drugs, Essential, Demography

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c119f3c5f02b00eb3581b2b9601107a4
https://pubmed.ncbi.nlm.nih.gov/31315833

المؤلفون: Lorenzo Moja, Worasuda Yoongthong, Monica Imi, Maria V. Villegas, Elisabeth G.E. de Vries, Bernadette Cappello, Nizal Sarrafzadegan, Evelina Tacconelli, Nicola Magrini, Armando A. Genazzani, Marc Mendelson, Gabriela Prutsky, Mike Sharland, Zeba Aziz, Gilbert Kokwaro, Shalini Sri Ranganathan, Sumanth Gandra, Franco Cavalli, Graham S Cooke, Stéphan Juergen Harbarth, Céline Pulcini, Mark Loeb, Dominik Mertz, Gregory L. Kearns, Mei Zeng, Benedikt Huttner, Fatima Suleman

المساهمون: Paediatric Infectious Diseases Research Group [London, UK], St George's, University of London-Institute for Infection and Immunity [London, UK], Washington University School of Medicine in St. Louis, Washington University in Saint Louis (WUSTL), Department of Infectious Diseases and Infection Control [Geneva, Switzerland], Hôpitaux Universitaires de Genève (HUG), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Service des Maladies Infectieuses et Tropicales [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Department of Infectious Diseases, Children's Hospital of Fudan University, Fudan University [Shanghai], University of Cape Town, Imperial College London, Centro de Estudos sobre a Mudança Socioeconómica (DINAMIA), Université de Lisbonne, Infection Control Programme and WHO Collaborating Centre on Patient Safety, Department of Infectious Diseases, Università cattolica del Sacro Cuore [Milano] (Unicatt), National Institute for Health Research

المصدر: The Lancet Infectious Diseases, Vol. 19, No 12 (2019) pp. 1278-1280
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2019, 19 (12), pp.1278-1280. ⟨10.1016/S1473-3099(19)30532-8⟩

مصطلحات موضوعية: medicine.medical_specialty, MEDLINE, Inappropriate Prescribing, Global Health, Microbiology, Essential medicines, Antimicrobial Stewardship, 03 medical and health sciences, 0302 clinical medicine, 1108 Medical Microbiology, medicine, Global health, Humans, 030212 general & internal medicine, Antibiotic use, EML Expert Committee and Antibiotic Working Group, Intensive care medicine, ComputingMilieux_MISCELLANEOUS, ddc:616, 0303 health sciences, 030306 microbiology, business.industry, 1103 Clinical Sciences, Anti-Bacterial Agents, 3. Good health, Anti-Bacterial Agents/therapeutic use, Infectious Diseases, Antimicrobial Stewardship/methods, Antibiotic Stewardship, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, Drugs, Essential

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc069ab9673b124cb5241431c2920ad
https://archive-ouverte.unige.ch/unige:144732